-
Bayern sign Morocco midfielder Saibari on five-year deal
-
Messi returns 'home' to lead Argentina World Cup charge in Miami
-
Hope fades, hunger sets in a week after Venezuela quakes
-
England skipper Sciver-Brunt 'threw everything' at World Cup semi-final return
-
Noosha Aubel: 10 km/h for residents – Potsdam’s approach to potholes: indifference or incompetence?
-
Stocks mixed with eyes on US Fed
-
Bayern to host Stuttgart in Bundesliga season opener
-
Trial begins for suspected mastermind of Malta journalist killing
-
US Fed chair says committed to combatting 'too high' prices
-
Traditionalist Catholic society defies Vatican by consecrating new bishops
-
Portugal braces for high temperatures in new heatwave
-
World number ones Sinner, Sabalenka into Wimbledon third round
-
Trump upbeat as US, Iran hold indirect talks in Qatar
-
Sony to stop releasing PlayStation games on discs
-
Sinner sinks Borges to step up Wimbledon title defence
-
All-white and lavender: Wimbledon hunts drought-resistant flowers
-
Thomas targets yellow in Tour team time-trial
-
Inter Milan laud veteran Mkhitaryan after deal extension
-
Bike - or even walk: World Cup fans improvise to reach NY venue
-
Vaughan calls for England coaching clear-out after Stokes exit
-
Swedish court orders Google pay nearly $2 bn for favouring its price comparisons
-
Sony says to stop releasing PlayStation games on discs
-
England breaks record for warmest June: Met Office
-
Sabalenka sets up Wimbledon third-round clash with Ostapenko
-
Stocks drop with eyes on US Fed
-
Planned 1.7 million satellites 'devastating' for astronomy: study
-
Barca have bid for Atletico's Alvarez: president Laporta
-
Trump defends earning more than $1bn on crypto
-
'Smart' and 'very rational'? Iran's new leaders post-Ali Khamenei
-
Sciver-Brunt fit for England's T20 World Cup semi-final
-
Bordeaux-Begles handed favourable draw in Champions Cup defence
-
Key challenges for Laporta in second Barca term
-
'Thought they'd never be caught': The strike that killed Iran's Khamenei
-
Canada to join Eurovision Song Contest
-
Djokovic, Sinner hope for easier ride after Wimbledon scares
-
Swedish court orders Google pay $1.46 bn for favouring its price comparisons
-
Injured Serena's Wimbledon doubles bid with sister Venus in doubt
-
German FA headquarters searched in Euro 2024 graft probe
-
European stocks mostly drop with eyes on US Fed
-
Village People singer Victor Willis dies at 74
-
Genesio replaces Beye as Marseille boss
-
Thousands rush to get tickets for Bayeux Tapestry's UK show
-
Catholic society defies Vatican again by ordaining new bishops
-
Chinese firm sells hyper-real, 'always loyal' humanoid robots
-
Breakaway Catholic society defies Vatican again by ordaining bishops
-
World's oceans break June heat record: EU monitor
-
Venezuelans search, suffer one week after deadly quakes
-
China imposes 'national security' rules on overseas investments
-
Asian stocks mostly up as traders eye crucial US jobs data
-
'Nothing left except death': Myanmar families grieve huge war toll
New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
F.Pavlenko--BTB